FDG-PET/CT and Para-Aortic Staging in Endometrial Cancer. A French Multicentric Study.

Currently, FDG-PET/CT alone cannot replace PAL for the lymph node evaluation of high-risk endometrial cancers. It seems essential to reread it in multidisciplinary meetings before validating the therapeutic management of patients, particularly in the case of isolated para-aortic involvement.